My Effective Treatment for psoriasisPsoriasis has been an issue for me for over 50 years. For the vast of those tears I had no idea what it was. It manifest itself as very dry...Reactions0reactionsComments1 replies
New medication anxiety A year ago I was on a biologic that put me in remission for my psoriasis, psoriatic arthritis and leukocytic colitis. My quality of life was excellent and I became...Reactions0reactionsComments1 repliesBiologicsCost
Psoriasis in the earsOk so to begin this I don't know what it is that's bothering my ears, I've had ear infection after ear infection since 2017 which I had chalked up to...Reactions0reactionsComments1 replies
RemissionI am seven or eight years in remission now. I have had very small patches since but nothing like I used to have. I had about 85% coverage for five...Reactions0reactionsComments5 repliesCoping
Featurednew diagnosis, treatment questionHello, I just recently received a diagnosis of psoriatic arthritis, 2 weeks ago, so this is all new to me. Well, reading others' stories, finding out I'm not alone, and...Reactions0reactionsComments2 replies
Otezla (Apremilast) - changes in one week !hi fellow amazing psoriasis friends. I have just started taking Otezla (Apremilast) which was recommended by the dermatologist for a week now and oh boy I am seeing some changes...Reactions0reactionsComments1 replies
I went to the Dermatologists, prescribed ApremilastHi All Just back from the Dermatologist and was prescribed Apremilast. It inhibits the activity of phosphodiesterase type-4 (PDE4) which results in suppression of pro-inflammatory mediator synthesis Whilst there, I...Reactions0reactionsComments6 repliesTreatment
Options for our younger 'members':Dewi here: Glacial progress: In December 2021, the U.S. Food and Drug Administration (FDA) approved Cosentyx® (secukinumab) for the treatment of active psoriatic arthritis (PsA) in patients 2 years and...Reactions0reactionsComments3 repliesAwareness
Latest Biologic - just in case:Dewi here: Not sure if you've seen this, so just in case: On January 21, 2022 the U.S. Food and Drug Administration (FDA) approved SKYRIZI® (risankizumab-rzaa), an interleukin-23 inhibitor, for...Reactions0reactionsComments1 replies
Under development:Drug companies are on the hunt for new ways to block inflammation in psoriatic disease. Some ideas involve combining biologics or targeting more than one inflammatory pathway at once. For...Reactions0reactionsComments3 replies